Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with PCOS should have an oral glucose tolerance test for effective diabetes screening.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Most women with excessive hair growth have a hormonal cause.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Obese women with PCOS are more likely to have fatty liver disease.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Women with acne have lower levels of a specific hormone marker than women without acne.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Chinese women with PCOS have higher androgen levels, which change with age and weight.